<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: As the complexity of microsimulation models increases, concerns about model transparency are heightened </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The authors conducted model "experiments" to explore the impact of variations in "deep" model parameters using 3 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) models </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> natural history models were calibrated to match observed data on <z:mpath ids='MPATH_270'>adenoma</z:mpath> prevalence and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence but varied in their underlying specification of the <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> process </plain></SENT>
<SENT sid="3" pm="."><plain>The authors projected <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> incidence among individuals with an underlying <z:mpath ids='MPATH_270'>adenoma</z:mpath> or preclinical <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> v. those without any underlying condition and examined the impact of removing <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>They calculated the percentage of simulated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cases arising from <z:mpath ids='MPATH_270'>adenomas</z:mpath> that developed within 10 or 20 years prior to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis and estimated dwell time-defined as the time from the development of an <z:mpath ids='MPATH_270'>adenoma</z:mpath> to symptom-detected <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in the absence of screening among individuals with a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> diagnosis </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The 20-year <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> incidence among 55-year-old individuals with an <z:mpath ids='MPATH_270'>adenoma</z:mpath> or preclinical <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was 7 to 75 times greater than in the condition-free group </plain></SENT>
<SENT sid="6" pm="."><plain>The removal of <z:hpo ids='HP_0000001'>all</z:hpo> <z:mpath ids='MPATH_270'>adenomas</z:mpath> among the subgroup with an underlying <z:mpath ids='MPATH_270'>adenoma</z:mpath> or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> resulted in a reduction of 30% to 89% in cumulative incidence </plain></SENT>
<SENT sid="7" pm="."><plain>Among <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> diagnosed at age 65 years, the proportion arising from <z:mpath ids='MPATH_270'>adenomas</z:mpath> formed within 10 years ranged between 4% and 67% </plain></SENT>
<SENT sid="8" pm="."><plain>The mean dwell time varied from 10.6 to 25.8 years </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Models that <z:hpo ids='HP_0000001'>all</z:hpo> match observed data on <z:mpath ids='MPATH_270'>adenoma</z:mpath> prevalence and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence can produce quite different dwell times and very different answers with respect to the effectiveness of interventions </plain></SENT>
<SENT sid="10" pm="."><plain>When conducting applied analyses to inform policy, using multiple models provides a sensitivity analysis on key (unobserved) "deep" model parameters and can provide guidance about specific areas in need of additional research and validation </plain></SENT>
</text></document>